Q6ITB4 AF NFT

Kunitz-type serine protease inhibitor microlepidin-2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiditqfd4mv2mvokccolf6c2jj32lroa7faz2x6e3nztytr5yg3qjq/metadata.json
IPFS of structure file: 
bafybeiht2e5rhwudz7feo6dctxwvdamujpjkrf45pxdha72xkapue3mlsq/AF-Q6ITB4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x3103931037B3C500a07b6CD5CC2934Cfc0d5Caa7
First NFT owner address (bech32): 
genesis1xypexyphk0zspgrmdn2uc2f5elqdtj48ekg7lf
Current NFT ID #496842 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
496842
Accession (UniProt):
Q6ITB4
Name::
Kunitz-type serine protease inhibitor microlepidin-2
Experimental Method:
Predicted structure
Sequence source:
Oxyuranus microlepidotus

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6ITB4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6ITB4|VKT2_OXYMI Kunitz-type serine protease inhibitor microlepidin-2 OS=Oxyuranus microlepidotus OX=111177 PE=2 SV=1 MSSGGLLLLLGLLTLWEVLTPVSSKDRPDFCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCEGNANNFITKEECESTCAA